The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 16, 2016
Filed:
Aug. 01, 2013
Applicant:
Pierre Fabre Medicament, Boulogne-Billancourt, FR;
Inventors:
Frédéric Marion, Toulouse, FR;
Frédéric Lieby-Muller, Portet-sur-Garonne, FR;
Serge Grisoni, Portet-sur-Garonne, FR;
Nicolas Rahier, Ayguesvives, FR;
Michel Perez, Castres, FR;
Isabelle Sartori, Toulouse, FR;
Assignee:
PIERRE FABRE MEDICAMENT, Boulogne-Billancourt, FR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 493/10 (2006.01); C07D 495/10 (2006.01); C07D 405/14 (2006.01); C07D 307/94 (2006.01); C07D 405/12 (2006.01); C07D 407/04 (2006.01); C07D 407/12 (2006.01); C07D 409/04 (2006.01); C07D 491/107 (2006.01);
U.S. Cl.
CPC ...
C07D 495/10 (2013.01); C07D 307/94 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01); C07D 407/04 (2013.01); C07D 407/12 (2013.01); C07D 409/04 (2013.01); C07D 491/107 (2013.01); C07D 493/10 (2013.01);
Abstract
The present invention relates to compounds of the following general formula (I), or to a pharmaceutically acceptable salt thereof, as well as to the uses thereof as a drug, in particular in the treatment of cancerous or precancerous hyperproliferative conditions, and to the pharmaceutical compositions containing same.